Global OTC Anti-Infective Medications Market Research Report 2022

Publisher Name :
Date: 10-Aug-2022
No. of pages: 87
Inquire Before Buying

OTC Anti-Infective Medications market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global OTC Anti-Infective Medications market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Antifungals

- Antiseptic

- Antiparasitics

Segment by Application

- Hospital Pharmacies

- Drug Stores

- E-Commerce

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- GlaxoSmithKline

- Merck

- Pfizer

- Novartis

- Abbott

- Sanofi

- Bristol-Myers Squibb

- Roche

- NanoViricides

- Novabay Pharmaceuticals

- Optimer Pharmaceuticals

- Basilea Pharmaceutica

- MerLion Pharma

Global OTC Anti-Infective Medications Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Medications Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Antifungals
1.2.3 Antiseptic
1.2.4 Antiparasitics
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Medications Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 E-Commerce
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Medications Market Perspective (2017-2028)
2.2 OTC Anti-Infective Medications Growth Trends by Region
2.2.1 OTC Anti-Infective Medications Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 OTC Anti-Infective Medications Historic Market Size by Region (2017-2022)
2.2.3 OTC Anti-Infective Medications Forecasted Market Size by Region (2023-2028)
2.3 OTC Anti-Infective Medications Market Dynamics
2.3.1 OTC Anti-Infective Medications Industry Trends
2.3.2 OTC Anti-Infective Medications Market Drivers
2.3.3 OTC Anti-Infective Medications Market Challenges
2.3.4 OTC Anti-Infective Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-Infective Medications Players by Revenue
3.1.1 Global Top OTC Anti-Infective Medications Players by Revenue (2017-2022)
3.1.2 Global OTC Anti-Infective Medications Revenue Market Share by Players (2017-2022)
3.2 Global OTC Anti-Infective Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Anti-Infective Medications Revenue
3.4 Global OTC Anti-Infective Medications Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Medications Revenue in 2021
3.5 OTC Anti-Infective Medications Key Players Head office and Area Served
3.6 Key Players OTC Anti-Infective Medications Product Solution and Service
3.7 Date of Enter into OTC Anti-Infective Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Medications Breakdown Data by Type
4.1 Global OTC Anti-Infective Medications Historic Market Size by Type (2017-2022)
4.2 Global OTC Anti-Infective Medications Forecasted Market Size by Type (2023-2028)
5 OTC Anti-Infective Medications Breakdown Data by Application
5.1 Global OTC Anti-Infective Medications Historic Market Size by Application (2017-2022)
5.2 Global OTC Anti-Infective Medications Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America OTC Anti-Infective Medications Market Size (2017-2028)
6.2 North America OTC Anti-Infective Medications Market Size by Country (2017-2022)
6.3 North America OTC Anti-Infective Medications Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe OTC Anti-Infective Medications Market Size (2017-2028)
7.2 Europe OTC Anti-Infective Medications Market Size by Country (2017-2022)
7.3 Europe OTC Anti-Infective Medications Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Medications Market Size (2017-2028)
8.2 Asia-Pacific OTC Anti-Infective Medications Market Size by Country (2017-2022)
8.3 Asia-Pacific OTC Anti-Infective Medications Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America OTC Anti-Infective Medications Market Size (2017-2028)
9.2 Latin America OTC Anti-Infective Medications Market Size by Country (2017-2022)
9.3 Latin America OTC Anti-Infective Medications Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Medications Market Size (2017-2028)
10.2 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2017-2022)
10.3 Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline OTC Anti-Infective Medications Introduction
11.1.4 GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck OTC Anti-Infective Medications Introduction
11.2.4 Merck Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer OTC Anti-Infective Medications Introduction
11.3.4 Pfizer Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis OTC Anti-Infective Medications Introduction
11.4.4 Novartis Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.4.5 Novartis Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott OTC Anti-Infective Medications Introduction
11.5.4 Abbott Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.5.5 Abbott Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi OTC Anti-Infective Medications Introduction
11.6.4 Sanofi Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.6.5 Sanofi Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb OTC Anti-Infective Medications Introduction
11.7.4 Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Company Detail
11.8.2 Roche Business Overview
11.8.3 Roche OTC Anti-Infective Medications Introduction
11.8.4 Roche Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.8.5 Roche Recent Development
11.9 NanoViricides
11.9.1 NanoViricides Company Detail
11.9.2 NanoViricides Business Overview
11.9.3 NanoViricides OTC Anti-Infective Medications Introduction
11.9.4 NanoViricides Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.9.5 NanoViricides Recent Development
11.10 Novabay Pharmaceuticals
11.10.1 Novabay Pharmaceuticals Company Detail
11.10.2 Novabay Pharmaceuticals Business Overview
11.10.3 Novabay Pharmaceuticals OTC Anti-Infective Medications Introduction
11.10.4 Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.10.5 Novabay Pharmaceuticals Recent Development
11.11 Optimer Pharmaceuticals
11.11.1 Optimer Pharmaceuticals Company Detail
11.11.2 Optimer Pharmaceuticals Business Overview
11.11.3 Optimer Pharmaceuticals OTC Anti-Infective Medications Introduction
11.11.4 Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.11.5 Optimer Pharmaceuticals Recent Development
11.12 Basilea Pharmaceutica
11.12.1 Basilea Pharmaceutica Company Detail
11.12.2 Basilea Pharmaceutica Business Overview
11.12.3 Basilea Pharmaceutica OTC Anti-Infective Medications Introduction
11.12.4 Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.12.5 Basilea Pharmaceutica Recent Development
11.13 MerLion Pharma
11.13.1 MerLion Pharma Company Detail
11.13.2 MerLion Pharma Business Overview
11.13.3 MerLion Pharma OTC Anti-Infective Medications Introduction
11.13.4 MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2017-2022)
11.13.5 MerLion Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global OTC Anti-Infective Medications Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Antifungals
Table 3. Key Players of Antiseptic
Table 4. Key Players of Antiparasitics
Table 5. Global OTC Anti-Infective Medications Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global OTC Anti-Infective Medications Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global OTC Anti-Infective Medications Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global OTC Anti-Infective Medications Market Share by Region (2017-2022)
Table 9. Global OTC Anti-Infective Medications Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global OTC Anti-Infective Medications Market Share by Region (2023-2028)
Table 11. OTC Anti-Infective Medications Market Trends
Table 12. OTC Anti-Infective Medications Market Drivers
Table 13. OTC Anti-Infective Medications Market Challenges
Table 14. OTC Anti-Infective Medications Market Restraints
Table 15. Global OTC Anti-Infective Medications Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global OTC Anti-Infective Medications Market Share by Players (2017-2022)
Table 17. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2021)
Table 18. Ranking of Global Top OTC Anti-Infective Medications Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by OTC Anti-Infective Medications Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players OTC Anti-Infective Medications Product Solution and Service
Table 22. Date of Enter into OTC Anti-Infective Medications Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global OTC Anti-Infective Medications Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global OTC Anti-Infective Medications Revenue Market Share by Type (2017-2022)
Table 26. Global OTC Anti-Infective Medications Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global OTC Anti-Infective Medications Revenue Market Share by Type (2023-2028)
Table 28. Global OTC Anti-Infective Medications Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global OTC Anti-Infective Medications Revenue Market Share by Application (2017-2022)
Table 30. Global OTC Anti-Infective Medications Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global OTC Anti-Infective Medications Revenue Market Share by Application (2023-2028)
Table 32. North America OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific OTC Anti-Infective Medications Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa OTC Anti-Infective Medications Market Size by Country (2023-2028) & (US$ Million)
Table 42. GlaxoSmithKline Company Detail
Table 43. GlaxoSmithKline Business Overview
Table 44. GlaxoSmithKline OTC Anti-Infective Medications Product
Table 45. GlaxoSmithKline Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 46. GlaxoSmithKline Recent Development
Table 47. Merck Company Detail
Table 48. Merck Business Overview
Table 49. Merck OTC Anti-Infective Medications Product
Table 50. Merck Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer OTC Anti-Infective Medications Product
Table 55. Pfizer Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis OTC Anti-Infective Medications Product
Table 60. Novartis Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Abbott Company Detail
Table 63. Abbott Business Overview
Table 64. Abbott OTC Anti-Infective Medications Product
Table 65. Abbott Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Sanofi Company Detail
Table 68. Sanofi Business Overview
Table 69. Sanofi OTC Anti-Infective Medications Product
Table 70. Sanofi Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. Bristol-Myers Squibb Company Detail
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb OTC Anti-Infective Medications Product
Table 75. Bristol-Myers Squibb Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 76. Bristol-Myers Squibb Recent Development
Table 77. Roche Company Detail
Table 78. Roche Business Overview
Table 79. Roche OTC Anti-Infective Medications Product
Table 80. Roche Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 81. Roche Recent Development
Table 82. NanoViricides Company Detail
Table 83. NanoViricides Business Overview
Table 84. NanoViricides OTC Anti-Infective Medications Product
Table 85. NanoViricides Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 86. NanoViricides Recent Development
Table 87. Novabay Pharmaceuticals Company Detail
Table 88. Novabay Pharmaceuticals Business Overview
Table 89. Novabay Pharmaceuticals OTC Anti-Infective Medications Product
Table 90. Novabay Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 91. Novabay Pharmaceuticals Recent Development
Table 92. Optimer Pharmaceuticals Company Detail
Table 93. Optimer Pharmaceuticals Business Overview
Table 94. Optimer Pharmaceuticals OTC Anti-Infective MedicationsProduct
Table 95. Optimer Pharmaceuticals Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 96. Optimer Pharmaceuticals Recent Development
Table 97. Basilea Pharmaceutica Company Detail
Table 98. Basilea Pharmaceutica Business Overview
Table 99. Basilea Pharmaceutica OTC Anti-Infective MedicationsProduct
Table 100. Basilea Pharmaceutica Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 101. Basilea Pharmaceutica Recent Development
Table 102. MerLion Pharma Company Detail
Table 103. MerLion Pharma Business Overview
Table 104. MerLion Pharma OTC Anti-Infective MedicationsProduct
Table 105. MerLion Pharma Revenue in OTC Anti-Infective Medications Business (2017-2022) & (US$ Million)
Table 106. MerLion Pharma Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Anti-Infective Medications Market Share by Type: 2021 VS 2028
Figure 2. Antifungals Features
Figure 3. Antiseptic Features
Figure 4. Antiparasitics Features
Figure 5. Global OTC Anti-Infective Medications Market Share by Application in 2021 & 2028
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Drug Stores Case Studies
Figure 8. E-Commerce Case Studies
Figure 9. OTC Anti-Infective Medications Report Years Considered
Figure 10. Global OTC Anti-Infective Medications Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global OTC Anti-Infective Medications Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global OTC Anti-Infective Medications Market Share by Region: 2021 VS 2028
Figure 13. Global OTC Anti-Infective Medications Market Share by Players in 2021
Figure 14. Global Top OTC Anti-Infective Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medications as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by OTC Anti-Infective Medications Revenue in 2021
Figure 16. North America OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America OTC Anti-Infective Medications Market Share by Country (2017-2028)
Figure 18. United States OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe OTC Anti-Infective Medications Market Share by Country (2017-2028)
Figure 22. Germany OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific OTC Anti-Infective Medications Market Share by Region (2017-2028)
Figure 30. China OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America OTC Anti-Infective Medications Market Share by Country (2017-2028)
Figure 38. Mexico OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa OTC Anti-Infective Medications Market Share by Country (2017-2028)
Figure 42. Turkey OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia OTC Anti-Infective Medications Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. GlaxoSmithKline Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 45. Merck Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 46. Pfizer Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 47. Novartis Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 48. Abbott Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 49. Sanofi Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 51. Roche Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 52. NanoViricides Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 53. Novabay Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 54. Optimer Pharmaceuticals Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 55. Basilea Pharmaceutica Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 56. MerLion Pharma Revenue Growth Rate in OTC Anti-Infective Medications Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs